Group One Trading, L.P. Amryt Pharma PLC Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$6.85 - $8.87 $125,245 - $162,179	-18,284 Reduced 99.67%	60 $0
Q1 2022 May 12, 2022	SELL	$6.3 - $10.86 $40,137 - $69,189	-6,371 Reduced 25.78%	18,344 $152,000
Q4 2021 Feb 11, 2022	BUY	$9.44 - $12.24 $1,510 - $1,958	160 Added 0.65%	24,715 $267,000
Q3 2021 Nov 12, 2021	BUY	$9.63 - $12.47 $236,464 - $306,200	24,555 New	24,555 $297,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.